Abstract

EE218 Budget Impact and Cost Minimization Analysis of Phesgo ® (Trastuzumab + Pertuzumab SC) for the Treatment of HER2+ Breast Cancer in the Chilean Public Health System

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P1-10-18: The use of hypofractionated radiotherapy for the treatment of women with early breast cancer in the Brazilian public health system may increase access to treatment: Cost effectiveness and budget impact analyses
Trdm Andrade ... Acp Nazário
American Journal of Cancer | VOL. 77
Trdm Andrade, et. al.Trdm Andrade ... Acp Nazário
14 Feb 2017
Review: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
Wim G Goettsch ... Joost Enzing
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 17
Wim G Goettsch, et. al.Wim G Goettsch ... Joost Enzing
31 Oct 2013
POSA164 Cost Minimization and Budget Impact Analysis of Viscosupplementation with Hylan G-F 20 for the Treatment of Knee Osteoarthrosis from the Perspective of the Public Sector in El Salvador and Panama
Y Gil Rojas ... P Lasalvia
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 25
Y Gil Rojas, et. al.Y Gil Rojas ... P Lasalvia
01 Jan 2021
The clinical use and cost-effectiveness of domestic blood coagulation factors VIII and IX
D S Fokina ... O V Zhukova
Pediatric Hematology/Oncology and Immunopathology | VOL. 21
D S Fokina, et. al.D S Fokina ... O V Zhukova
29 Mar 2022
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
View more papers